Literature DB >> 32496451

Lymphoma Classification.

Laurence de Leval1, Elaine S Jaffe2.   

Abstract

Twenty-five years after the Revised European American Classification of Lymphoid Neoplasms classification was published, its principle of an integrative approach to disease definition based on several parameters still prevails and has been adopted and expanded in the following World Health Organization classifications of tumors of the hematopoietic organs. The latest World Health Organization classification revised in 2017 comprises more than 80 entities of mature lymphoid neoplasms (B-cell, T-cell, and Hodgkin lymphomas), which are defined according to their morphology, immunophenotype, genetic lesions and molecular profiles, clinical features, and cellular derivation. The classification also recognizes both incipient and indolent lymphoid neoplasms with a low potential of progression. In this review, we highlight some of the new data and recent modifications introduced in the 2017 classification.

Entities:  

Mesh:

Year:  2020        PMID: 32496451     DOI: 10.1097/PPO.0000000000000451

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  18 in total

1.  LBD: a manually curated database of experimentally validated lymphoma biomarkers.

Authors:  Bin Tan; Saige Xin; Yanshi Hu; Cong Feng; Ming Chen
Journal:  Database (Oxford)       Date:  2022-07-05       Impact factor: 4.462

Review 2.  Sphingolipids and Lymphomas: A Double-Edged Sword.

Authors:  Alfredo Pherez-Farah; Rosa Del Carmen López-Sánchez; Luis Mario Villela-Martínez; Rocío Ortiz-López; Brady E Beltrán; José Ascención Hernández-Hernández
Journal:  Cancers (Basel)       Date:  2022-04-19       Impact factor: 6.575

3.  Racial Disparities in Survival Among Non-Hodgkin Lymphoma Patients: An Analysis of the SEER Database (2007-2015).

Authors:  Faith O Abodunrin; Oluwasegun A Akinyemi; Ademola S Ojo; Kindha Elleissy Nasef; Thomas Haupt; Ayobami Oduwole; Oni Olanrewaju; Bolarinwa Akinwumi; Mary Fakorede; Oluwaseun Ogunbona
Journal:  Cureus       Date:  2022-06-12

Review 4.  The inflammasomes: crosstalk between innate immunity and hematology.

Authors:  Valéria de Freitas Dutra; Vinicius Nunes Cordeiro Leal; Alessandra Pontillo
Journal:  Inflamm Res       Date:  2022-10-20       Impact factor: 6.986

5.  Lacrimal sac lymphoma: a case series and literature review.

Authors:  Feng-Xi Meng; Han Yue; Yi-Qun Yuan; Rui Zhang; Yi-Fei Yuan; Ying-Wen Bi; Jiang Qian
Journal:  Int J Ophthalmol       Date:  2022-10-18       Impact factor: 1.645

Review 6.  MDSCs and T cells in solid tumors and non-Hodgkin lymphomas: an immunosuppressive speech.

Authors:  Chiara Cioccarelli; Barbara Molon
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

Review 7.  Role of Radiomics-Based Baseline PET/CT Imaging in Lymphoma: Diagnosis, Prognosis, and Response Assessment.

Authors:  Han Jiang; Ang Li; Zhongyou Ji; Mei Tian; Hong Zhang
Journal:  Mol Imaging Biol       Date:  2022-01-14       Impact factor: 3.484

Review 8.  Rare Diseases of the Orbit.

Authors:  Ulrich Kisser; Jens Heichel; Alexander Glien
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

Review 9.  Epidemiology of Non-Hodgkin's Lymphoma.

Authors:  Krishna C Thandra; Adam Barsouk; Kalyan Saginala; Sandeep Anand Padala; Alexander Barsouk; Prashanth Rawla
Journal:  Med Sci (Basel)       Date:  2021-01-30

Review 10.  Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics.

Authors:  Daniel J García-Domínguez; Lourdes Hontecillas-Prieto; Natalia Palazón-Carrión; Carlos Jiménez-Cortegana; Víctor Sánchez-Margalet; Luis de la Cruz-Merino
Journal:  Cancers (Basel)       Date:  2022-03-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.